Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acyline pharmacokinetics in healthy men
NCT00603187Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jan 2008
- Primary completion
- Feb 2008
- Countries
- 1
01
Overview
Phase 2, open-label trial of acyline in prostate cancer (PCa), precocious puberty and male contraception, sponsored by University of Washington. Primary endpoint: Testosterone Blood Serum Concentration at 7 days. Started Jan 2008; status: completed.
02
Drugs
acyline
03
Conditions
prostate cancer (PCa)precocious pubertymale contraception
Beyond the preview
Go deeper on NCT00603187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603187.